One of the most remarkable recent developments in the field of soft tissue sarcomas is the awareness that many of the types that had been previously identified on morphologic grounds (and further categorized with ultrastructural and immunohistochemical methods) are associated with specific or quasi-specific cytogenetic alterations, usually in the form of chromosomal translocations [1] . Significantly for the purpose of this discussion, no similar pattern has emerged for most other major tumor types such as carcinomas or melanomas.
The many studies that have been performed in the past few years correlating cytogenetic and morphologic parameters in soft tissue sarcomas have clarified the relationships that exist among them (as in Ewing sarcoma/primitive neuroectodermal tumor [PNET] or in myxoid/round cell liposarcoma) [2, 3] , have validated the existence of some entities (such as desmoplastic small cell tumor) [4] , and have provided a powerful additional tool for the diagnosis of cases that may not be easily categorized on morphologic and immunohistochemical grounds (such as monophasic synovial sarcoma) [5] . These correlations have also brought to light some unexpected and highly intriguing links between seemingly unrelated tumor types (such as alveolar soft part sarcoma and a peculiar variant of renal cell carcinoma) [6] .
A tumor type for which the opinions about its presumed nature have shifted back and forth as a result of the progressive information obtained on it in the course of the years is the entity originally identified by Enzinger in 1965 as clear cell sarcoma of tendons and aponeuroses (CCSTA) [7] . The tumors he de-scribed occurred chiefly in young adults, especially women, and were most common in the region of the foot and knee. They were intimately bound to tendons or aponeuroses and were composed of nests or aggregates of round or spindle, pale-staining cells showing prominent nucleoli. They manifested a tendency for local recurrence and eventual development of metastases after a protracted clinical course.
Dr. Enzinger was very circumspect about "the cell of origin" of this tumor. As a matter of fact, he candidly admitted that the identification of such cell was not possible with the means he had employed. Interestingly, he considered the possibility of melanoma (in part because of the presence of a brownish Fontana-positive pigment in occasional tumor cells) but thought it unlikely on the basis of the tumor morphology, the prolonged clinical course, and the absence of pigmented skin lesions. His choice of the term CCSTA was acknowledged to be purely descriptive and reflective of the uncertainty of the histogenesis, but clearly expressing a preference for the generic category of primary malignant tumors of soft tissues, i.e., the sarcomas.
Enzinger and Chung revisited the issue in 1983 [8] . The authors confirmed the status of CCSTA as a bona fide morphologic tumor entity but this time offered a substantially different view of its histogenesis. They reinterpreted the lesion as a malignant melanoma of soft parts on the basis of the frequent occurrence of melanin (demonstrable with the Fontana or Warthin-Starry preparations), the frequent immunoreactivity for S-100 protein, and the demonstration of premelanosomes at the ultrastructural level. They still expressed some perplexi-ties about the precise histogenesis but thought that the above-cited features supported an origin from migrated neural crest cells with the capacity for producing melanin. Therefore, they thought it was safe to conclude that "clear cell sarcoma represents a malignant neuroectodermal tumor derived from potentially melanogenic cells that have migrated from the neural crest during embryonal life" and "that the tumor is in many ways akin to malignant melanoma and malignant blue nevus."
There is a subtle point made here, which may have escaped the attention of most readers (it certainly escaped mine when I first read it). To be "akin to" malignant melanoma is not exactly the same as "being" a malignant melanoma. In other words, the authors thought that the tumor had enough melanoma-type attributes to be called such, but they still felt that there was something special about it, that this was not merely a conventional malignant melanoma that happened to be deep-seated. This important point tended to be ignored or minimized in most subsequent papers on the subject, which emphasized the melanomatous attributes of CCSTA over its other characteristics, partially influenced by the fact that cases of CCSTA were found to match the increasingly detailed immunohistochemical profile of conventional melanoma (including HMB-45, MelanA, and microphtalmia transcription factor reactivity) [9] , and by the finding of CCSTAtype tumors in sites other than around tendons and aponeuroses, and indeed outside the soft tissues, particularly in the gastrointestinal tract [10] .
Then something very interesting happened: the discovery that CCSTA was consistently associated with the t(12;22)(q13;q12) chromosomal translocation, leading to the formation of the EWS-ATF1 fusion transcript [11] . This was a most unexpected and perplexing finding, being that this chromosomal aberration was a "sarcoma-type" translocation (particularly because of the involvement of the EWS gene), and that nothing of the kind had ever been detected in conventional malignant melanoma. This finding led to an interesting quandary: should CC-STA be regarded as a melanoma because it makes melanin, or as a sarcoma because it is located in the deep soft tissues and has a chromosomal translocation of the type generally seen in sarcomas? As usual, the answer to the question depends on definitions, which in turn depend on the criteria chosen. If one were to define melanoma as any malignant tumor that possesses the cellular machinery to manufacture melanin and that actually produces this pigment, then CCSTA clearly qualifies as such. One could instead take a more restricted view of melanoma by pointing out that there any many types of neoplasms that make melanin but that are not regarded as melanomas, at least in the conventional sense of the word. Examples include pigmented malignant peripheral nerve sheath tumor, pigmented neuroectodermal tumor of infancy, malignant cellular blue nevus, and (at the risk of getting in high waters) malignant Spitz nevus.
This was the state of affairs when 6 cases of a distinctive tumor type in the gastrointestinal tract characterized by a population of S-100-protein-positive mononuclear cells associated with a scattering of osteoclasts were described by Zambrano et al [12] . The most intriguing aspect of this report was the fact that the single case from the group that had been studied cytogenetically (their Case 1) had the CCSTA translocation, despite the fact that neither the morphology nor the immunohistochemical profile (negativity for HMB-45 and Mart-1) were typical of CCSTA. In this issue of the journal, Friedricks et al report a similar case located in the small bowel, in which the t(12;22)(q13;q12) translocation was again detected, this time employing 2 different FISH strategies [13] . At this point, I think it is safe to conclude that we are indeed dealing with a distinctive entity, the main question being what relationship it bears with conventional CCSTA and whether its existence throws any light on the melanomatous versus sarcomatous nature of the latter. If we were to postulate that the Zambrano-Friedricks tumor and CCSTA belong to the same category because of their identical chromosomal aberration, this would place CCSTA at an even greater distance from conventional melanoma, because there is certainly very little that is melanoma-like (other than the S-100 protein positivity) about the Zambrano-Friedrick tumor.
To add yet another twist to this saga, Cvovinsky et al [14] recently found the CCSTA-type gene fusion transcript in 2 of 20 cases of gastrointestinal tumors that had been previously diagnosed as malignant melanomas and that were presumed to be metastatic (1 of the patients having a remote history of vulvar melanoma).
To summarize this complex situation, there is a t(12;22)(q13;q12) tumor of the gastrointestinal tract that ranges in morphology from an S-100-protein-positive HMB-45-negative osteoclast-rich tumor to a classic S-100-protein-positive, HMB-45positive melanin-containing classic CCSTA. Should it be viewed as a single tumor type, as supported by the cytogenetic marker, or as 2 different tumors, as suggested by the morphology and immunohistochemical profile? What is its (their) relationship with conventional melanoma, if any? A comprehensive analysis of additional cases will be necessary to unravel this fascinating issue.
